-
1
-
-
13344284635
-
A reversible posterior leukoencephalopathy syndrome
-
[PMID: 8559202 DOI: 10.1056/ NEJM199602223340803]
-
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500 [PMID: 8559202 DOI: 10.1056/ NEJM199602223340803]
-
(1996)
N Engl J Med
, vol.334
, pp. 494-500
-
-
Hinchey, J.1
Chaves, C.2
Appignani, B.3
Breen, J.4
Pao, L.5
Wang, A.6
Pessin, M.S.7
Lamy, C.8
Mas, J.L.9
Caplan, L.R.10
-
2
-
-
42949149159
-
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
-
[PMID: 18421054 DOI: 10.1200/JCO.2007.14.9930]
-
Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26: 2013-2019 [PMID: 18421054 DOI: 10.1200/JCO.2007.14.9930]
-
(2008)
J Clin Oncol
, vol.26
, pp. 2013-2019
-
-
Saltz, L.B.1
Clarke, S.2
Díaz-Rubio, E.3
Scheithauer, W.4
Figer, A.5
Wong, R.6
Koski, S.7
Lichinitser, M.8
Yang, T.S.9
Rivera, F.10
Couture, F.11
Sirzén, F.12
Cassidy, J.13
-
3
-
-
39149108869
-
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: Updated results from the BICC-C study
-
[PMID: 18235136 DOI: 10.1200/ JCO.2007.15.5390]
-
Fuchs CS, Marshall J, Barrueco J. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol 2008; 26: 689-690 [PMID: 18235136 DOI: 10.1200/ JCO.2007.15.5390]
-
(2008)
J Clin Oncol
, vol.26
, pp. 689-690
-
-
Fuchs, C.S.1
Marshall, J.2
Barrueco, J.3
-
4
-
-
0017168828
-
Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study
-
[PMID: 184880 DOI: 10.1016/0006-8993(76)9035 6-5]
-
Edvinsson L, Owman C, Sjöberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976; 115: 377-393 [PMID: 184880 DOI: 10.1016/0006-8993(76)9035 6-5]
-
(1976)
Brain Res
, vol.115
, pp. 377-393
-
-
Edvinsson, L.1
Owman, C.2
Sjöberg, N.O.3
-
5
-
-
78649422002
-
Posterior reversible encephalopathy syndrome and venous thrombosis
-
[PMID: 21111130 DOI: 10.1016/j.rcl.2010.07.016]
-
Petrovic BD, Nemeth AJ, McComb EN, Walker MT. Posterior reversible encephalopathy syndrome and venous thrombosis. Radiol Clin North Am 2011; 49: 63-80 [PMID: 21111130 DOI: 10.1016/j.rcl.2010.07.016]
-
(2011)
Radiol Clin North Am
, vol.49
, pp. 63-80
-
-
Petrovic, B.D.1
Nemeth, A.J.2
McComb, E.N.3
Walker, M.T.4
-
6
-
-
84859908843
-
Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
-
[PMID: 21768795 DOI: 10.1097/01. cad.0000398727.68461.77]
-
Rocha JA. Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer. Anticancer Drugs 2011; 22 Suppl 2: S9-S13 [PMID: 21768795 DOI: 10.1097/01. cad.0000398727.68461.77]
-
(2011)
Anticancer Drugs
, vol.22
, Issue.SUPPL. 2
-
-
Rocha, J.A.1
-
7
-
-
0026602484
-
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole
-
[PMID: 1637134 DOI: 10.1002/ana.410310306]
-
Hook CC, Kimmel DW, Kvols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriguez M. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992; 31: 262-267 [PMID: 1637134 DOI: 10.1002/ana.410310306]
-
(1992)
Ann Neurol
, vol.31
, pp. 262-267
-
-
Hook, C.C.1
Kimmel, D.W.2
Kvols, L.K.3
Scheithauer, B.W.4
Forsyth, P.A.5
Rubin, J.6
Moertel, C.G.7
Rodriguez, M.8
-
8
-
-
33644586050
-
Reversible posterior leukoencephalopathy syndrome and bevacizumab
-
discussion 980-982 [PMID: 16510760 DOI: 10.1056/NEJMc052954]
-
Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006; 354: 980-982; discussion 980-982 [PMID: 16510760 DOI: 10.1056/NEJMc052954]
-
(2006)
N Engl J Med
, vol.354
, pp. 980-982
-
-
Glusker, P.1
Recht, L.2
Lane, B.3
-
9
-
-
33750344252
-
Bevacizumab in the treatment of metastatic colorectal cancer: Safety profile and management of adverse events
-
[PMID: 17145522 DOI: 10.1053/j.seminoncol.2006.08.001]
-
Hurwitz H, Saini S. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol 2006; 33: S26-S34 [PMID: 17145522 DOI: 10.1053/j.seminoncol.2006.08.001]
-
(2006)
Semin Oncol
, vol.33
-
-
Hurwitz, H.1
Saini, S.2
-
10
-
-
25644449640
-
Pathophysiological consequences of VEGF-induced vascular permeability
-
[PMID: 16177780 DOI: 10.1038/nature03987]
-
Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437: 497-504 [PMID: 16177780 DOI: 10.1038/nature03987]
-
(2005)
Nature
, vol.437
, pp. 497-504
-
-
Weis, S.M.1
Cheresh, D.A.2
-
11
-
-
39649097820
-
Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab
-
[PMID: 18290962 DOI: 10.1111/j.1442-9071.2007.01658.x]
-
Peter S, Hausmann N, Schuster A, Boehm HF. Reversible posterior leukoencephalopathy syndrome and intravenous bevacizumab. Clin Experiment Ophthalmol 2008; 36: 94-96 [PMID: 18290962 DOI: 10.1111/j.1442-9071.2007.01658.x]
-
(2008)
Clin Experiment Ophthalmol
, vol.36
, pp. 94-96
-
-
Peter, S.1
Hausmann, N.2
Schuster, A.3
Boehm, H.F.4
-
12
-
-
49749145903
-
Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: Report of a case
-
[PMID: 18470563 DOI: 10.1007/s10350-008-9282-8]
-
Koopman M, Muller EW, Punt CJ. Reversible posterior leukoencephalopathy syndrome caused by bevacizumab: report of a case. Dis Colon Rectum 2008; 51: 1425-1426 [PMID: 18470563 DOI: 10.1007/s10350-008-9282-8]
-
(2008)
Dis Colon Rectum
, vol.51
, pp. 1425-1426
-
-
Koopman, M.1
Muller, E.W.2
Punt, C.J.3
-
13
-
-
33749587286
-
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer
-
[PMID: 17030665 DOI: 10.1001/archneur. 63.10.1475]
-
Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006; 63: 1475-1478 [PMID: 17030665 DOI: 10.1001/archneur. 63.10.1475]
-
(2006)
Arch Neurol
, vol.63
, pp. 1475-1478
-
-
Allen, J.A.1
Adlakha, A.2
Bergethon, P.R.3
-
14
-
-
4243057261
-
Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies
-
[PMID: 15307110 DOI: 10.1002/ajh.20147]
-
Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. Am J Hematol 2004; 77: 72-76 [PMID: 15307110 DOI: 10.1002/ajh.20147]
-
(2004)
Am J Hematol
, vol.77
, pp. 72-76
-
-
Tam, C.S.1
Galanos, J.2
Seymour, J.F.3
Pitman, A.G.4
Stark, R.J.5
Prince, H.M.6
-
15
-
-
66949140795
-
Understanding and managing the possible adverse effects associated with bevacizumab
-
[PMID: 19451611 DOI: 10.2146/ajhp080455]
-
Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm 2009; 66: 999-1013 [PMID: 19451611 DOI: 10.2146/ajhp080455]
-
(2009)
Am J Health Syst Pharm
, vol.66
, pp. 999-1013
-
-
Shord, S.S.1
Bressler, L.R.2
Tierney, L.A.3
Cuellar, S.4
George, A.5
|